Public Notice on EIA for Yunnan Investment Forestry and Pulp’s 760,000 tpy Chemical Pulp Technical Renovation and Expansion Project On May 14, Yunnan Investment Forestry and Pulp Co., Ltd. issued the second public notice on the environmental impact assessment (EIA) for its technical renovation and expansion project of 760,000 tpy chemical pulp. Adopting the mode of developing new facilities to upgrade existing ones, the project targets the green, low-carbon and intelligent transformation of the integrated forest-pulp-paper industry. A new 500,000 tpy chemical pulp production line will be built based on the existing lines, bringing the total designed capacity to 760,000 tpy.

Sichuan Dazhou Releases Dazhou Paper Industry Development Plan, Tissue Paper Capacity to Reach 700,000 tpy by 2029 Recently, Dazhou City, Sichuan Province issued the Dazhou Paper Industry Development Plan (Revised) (2025—2029), which proposes that by 2029, the city’s total bamboo pulp paper capacity will be significantly increased. Specifically, bamboo pulp capacity will reach 618,000 tpy, parent tissue roll and finished tissue paper capacity will each reach 700,000 tpy, and bamboo fiber capacity will reach 30,000 tpy. The planning covers the period from 2025 to 2029. The plan is divided into two phases: the first phase covers 2025 to 2027, and the second phase covers 2028 to 2029.

Winner Medical Launches Production Investment Project in Vietnam, Core Product Lines to Achieve Mass Production in Q3 2027 On May 18, the production investment project of Winner Medical Co., Ltd. in Vietnam kicked off at Haihe Industrial Park. With a total investment of approximately 60 million US dollars and a land area of around 93,000 square meters, the project is expected to launch mass production of its core product lines in the third quarter of 2027.

Xianhe Co., Ltd. Releases 2025 Annual Report, Plans to Advance Tissue Paper Project at Hubei Base In 2025, Xianhe Co., Ltd. posted operating revenue of approximately RMB 12.343 billion, a year-on-year increase of 20.14%. During the reporting period, Hubei Xianhe accelerated the progress of the tissue paper project. The installation and commissioning of production lines were completed ahead of schedule, followed by successful trial runs. The project officially launched production and sales in January 2025, with annual sales volume reaching around 46,900 tons.

Xianhe Co., Ltd. Releases 2025 Annual Report, Plans to Advance Tissue Paper Project at Hubei Base In 2025, Xianhe Co., Ltd. posted operating revenue of approximately RMB 12.343 billion, a year-on-year increase of 20.14%. During the reporting period, Hubei Xianhe accelerated the progress of the tissue paper project. The installation and commissioning of production lines were completed ahead of schedule, followed by successful trial runs. The project officially launched production and sales in January 2025, with annual sales volume reaching around 46,900 tons.

U-play Achieved Operating Revenue of Approximately RMB 1.168 Billion in 2025 Wuhu U-play Nursing Products Technology Co., Ltd. achieved operating revenue of approximately RMB 1.168 billion in 2025, representing a year-on-year increase of 14.43%. Net profit attributable to shareholders of the listed company was approximately RMB 36.1401 million, down 38.89% year-on-year.

Jingxing Paper Achieved Operating Revenue of Approximately RMB 6.012 Billion in 2025 Zhejiang Jingxing Paper Co., Ltd. achieved operating revenue of RMB 6.012 billion in 2025, representing a year-on-year increase of 9.72%. The tissue paper division produced 147,800 tpy of parent tissue roll, up 7.33% year-on-year, of which 137,000 tpy were directly sold externally, up 7.2% year-on-year.

OK Technology Publishes 2025 Annual Report and 2026 Q1 Report Recently, OK Technology Co., Ltd. achieved operating revenue of approximately RMB 956 million in 2025, representing a year-on-year increase of 120.01%. Net profit attributable to shareholders of the listed company was approximately RMB 40.8560 million, up 19.16% year-on-year. In the first quarter of 2026, the company achieved operating revenue of approximately RMB 256 million, up 28.33% year-on-year. Net profit attributable to shareholders of the listed company was approximately RMB 30.7723 million, down 24.08% year-on-year.

Focus Hotmelt Achieved Operating Revenue of Approximately RMB 588 Million in Q1 2026 Focus Hotmelt New Materials Co., Ltd. achieved operating revenue of approximately RMB 588 million in the first quarter of 2026, representing a year-on-year increase of 16.92%. Net profit attributable to shareholders of the listed company was approximately RMB 39.7472 million, up 11.91% year-on-year.

Xiamen Yanjan Achieved Operating Revenue of Approximately RMB 476 Million in Q1 2026 Xiamen Yanjan New Materials Co., Ltd. achieved operating revenue of approximately RMB 476 million in the first quarter of 2026, representing a year-on-year increase of 9.07%. Net profit attributable to shareholders of the listed company was approximately RMB 31.4168 million, up 182.90% year-on-year.

Jieya Achieved Operating Revenue of Approximately RMB 192 Million in Q1 2026 Tongling Jieya Biotechnology Co., Ltd. achieved operating revenue of approximately RMB 192 million in the first quarter of 2026, representing a year-on-year increase of 55.45%. Net profit attributable to shareholders of the listed company was approximately RMB 10.2685 million, up 2.04% year-on-year.